.png)
MIEBO Eye Drops: What Are They Used For and How Do They Treat Dry Eye?
Dry eye does not always happen because your eyes fail to produce enough tears.
For many people, the problem is that tears evaporate too quickly.
MIEBO is a prescription eye drop designed to address this part of dry eye disease. Its active ingredient, perfluorohexyloctane, spreads across the tear film and forms a thin layer at its surface. This layer is expected to reduce tear evaporation.
That makes MIEBO different from traditional artificial tears, which mainly add moisture to the surface of the eye.
MIEBO is FDA-approved for the treatment of the signs and symptoms of dry eye disease.
Understanding how the tear film works helps explain why this treatment is useful for certain patients.
1. What is MIEBO?
MIEBO is the brand name for perfluorohexyloctane ophthalmic solution.
It is a prescription eye drop approved in the United States for dry eye disease.
Unlike many eye drops, MIEBO is water-free. The solution contains 100% perfluorohexyloctane.
The medication belongs to a class of substances known as semifluorinated alkanes.
Rather than simply adding more liquid to the eye, MIEBO spreads across the surface of the tear film.
Its properties help create a barrier at the interface between tears and the air.
2. Why do tears evaporate too quickly?
The tear film is more complex than a layer of water.
It contains several components working together to keep the eye comfortable and maintain a smooth optical surface.
One important component is the lipid layer, which comes largely from small oil-producing glands in the eyelids called meibomian glands.
These oils help slow evaporation.
If the meibomian glands do not release enough healthy oil, tears evaporate more rapidly.
This is known as evaporative dry eye.
A major cause is meibomian gland dysfunction, or MGD.
3. What is meibomian gland dysfunction?
Meibomian glands sit along the edges of the upper and lower eyelids.
Every time you blink, these glands normally release oils into the tear film.
With MGD, the glands become blocked or the oil becomes thicker and less effective.
The tear film then becomes unstable and evaporates faster.
Symptoms often include:
burning
stinging
gritty eyes
fluctuating vision
redness
tired eyes
sensitivity to wind
discomfort with prolonged screen use
contact lens discomfort
MGD is extremely common and is an important contributor to evaporative dry eye.
4. How does MIEBO work?
MIEBO behaves differently from a typical water-based artificial tear.
Perfluorohexyloctane spreads quickly across the surface of the tear film and forms a thin monolayer.
This layer is expected to slow evaporation from the tear surface.
Laboratory research has shown that perfluorohexyloctane significantly reduces evaporation when placed over a liquid surface.
The exact biological mechanism through which MIEBO improves dry eye disease is not completely known, but reducing tear evaporation is a central part of how the medication is understood to work.
5. Is MIEBO an artificial tear?
Not in the usual sense.
Most over-the-counter artificial tears provide temporary lubrication by adding fluid or ingredients that help stabilize the ocular surface.
MIEBO takes a different approach.
Instead of primarily replacing the watery part of tears, it targets excessive evaporation.
That distinction is particularly relevant for patients whose dry eye is strongly related to the lipid layer or meibomian gland dysfunction.
Some patients still use artificial tears alongside prescription treatment based on their doctor's recommendations.
6. Who is MIEBO used for?
MIEBO is FDA-approved for the signs and symptoms of dry eye disease.
Its major clinical trials enrolled adults with dry eye disease who also had signs of meibomian gland dysfunction.
For this reason, MIEBO is especially relevant when excessive tear evaporation is an important part of the dry eye problem.
Possible symptoms include:
dryness
burning
grittiness
irritation
fluctuating vision
discomfort that worsens throughout the day
An eye examination helps determine which type of dry eye is present.
Not everyone with dry eye has the same underlying problem.
7. How is MIEBO different from other prescription dry eye drops?
Prescription dry eye treatments work in different ways.
Some treatments primarily target inflammation.
Others help increase tear production.
MIEBO focuses on reducing tear evaporation.
This means two people with similar symptoms might receive different treatments depending on what is happening on the surface of their eyes.
Dry eye treatment is often individualized rather than based on symptoms alone.
8. How often is MIEBO used?
The current FDA prescribing information recommends:
One drop in the affected eye or eyes four times daily.
Follow the instructions provided by your prescribing clinician.
Do not increase or decrease the frequency without discussing the change with your eye-care team.
Consistency matters because dry eye disease is often chronic rather than a problem solved by one or two doses.
9. Why does the MIEBO bottle work differently?
Patients sometimes notice that the bottle instructions feel different from ordinary eye drops.
The FDA instructions involve:
Removing the cap.
Holding the bottle upright and gently squeezing it.
Turning the bottle upside down while releasing pressure so air enters the bottle.
Keeping it upside down and squeezing again to release one drop.
The bottle design reflects the physical properties of the water-free solution.
Following the supplied instructions helps dispense the medication properly.
10. What does MIEBO feel like in the eye?
Experiences vary between patients.
Because MIEBO is water-free and has different physical properties from standard artificial tears, it sometimes feels different from drops patients have used before.
Temporary blurred vision is one of the reported side effects.
In clinical trials, blurred vision occurred in a small percentage of patients and was generally temporary.
If vision remains significantly blurred or symptoms worsen after using any new medication, contact the prescribing clinician.
11. What are the most common side effects?
According to current prescribing information, blurred vision was the most common ocular adverse reaction.
Blurred vision and conjunctival redness were reported in a small proportion of participants in clinical trials.
Hypersensitivity reactions have also been reported.
MIEBO should not be used in someone with a history of hypersensitivity to perfluorohexyloctane.
Contact your healthcare provider if you develop significant redness, swelling, irritation, or another reaction after beginning treatment.
12. What if you wear contact lenses?
Contact lenses should be removed before using MIEBO.
Current prescribing information says lenses should remain out for at least 30 minutes after the drop is administered.
Do not place the medication directly into an eye while wearing contact lenses.
If dry eye repeatedly makes contact lens wear uncomfortable, discuss this with your eye-care provider as well.
The lens itself, wearing schedule, and ocular surface all influence comfort.
13. How quickly does MIEBO start working?
Dry eye treatment is different from using a pain reliever where a patient expects an immediate, obvious effect.
Clinical trials evaluated changes over several weeks.
In the pivotal MIEBO studies, improvements in both dry eye signs and reported dryness symptoms were observed during the treatment period.
Some people notice symptom improvement earlier than others.
Response depends on the type and severity of dry eye and other factors affecting the ocular surface.
14. What did the clinical trials find?
MIEBO was evaluated in two major randomized controlled studies called GOBI and MOJAVE.
Together, these studies included more than 1,200 people with dry eye disease and clinical signs of meibomian gland dysfunction.
Participants receiving MIEBO used the drops four times daily.
Researchers evaluated both:
visible signs of damage on the corneal surface
patients' reported eye dryness
By days 15 and 57, MIEBO showed greater improvement than the saline comparison group for both measures.
These studies supported the FDA approval of MIEBO for dry eye disease.
15. Does MIEBO cure dry eye?
Dry eye disease is often a long-term condition influenced by several factors.
Treatment focuses on controlling symptoms, improving tear-film stability, and protecting the ocular surface.
MIEBO addresses excessive tear evaporation, but other contributors still need attention.
These include:
meibomian gland blockage
eyelid inflammation
screen habits
environmental exposure
medications
contact lens use
autoimmune disease
hormonal changes
Some patients therefore need a combination of treatments.
16. Does MIEBO treat blocked meibomian glands?
MIEBO targets the tear evaporation associated with dry eye.
It does not physically unblock a meibomian gland.
Patients with significant MGD sometimes benefit from additional measures aimed at the eyelids and glands.
Depending on the individual, a treatment plan might include:
warm compresses
eyelid hygiene
treatment of eyelid inflammation
in-office meibomian gland treatments
other prescription medications
The right combination depends on the examination findings.
17. Is MIEBO preservative-free?
MIEBO contains 100% perfluorohexyloctane and does not rely on the preservatives found in many traditional multidose eye drops.
This is relevant for people who use drops frequently because some ocular surfaces are sensitive to repeated preservative exposure.
However, preservative-free does not automatically mean a medication is right for every patient.
The type of dry eye still matters.
18. Is MIEBO the same as lubricating eye drops from the pharmacy?
No.
MIEBO is a prescription medication with a specific active ingredient and FDA-approved indication.
Over-the-counter lubricating drops come in many formulations, including:
watery artificial tears
gel drops
lipid-based tears
preservative-free tears
nighttime ointments
These products remain useful for many patients.
MIEBO adds another treatment option, particularly when evaporation is an important part of the disease.
19. Why does screen use make evaporative dry eye worse?
People blink less frequently while concentrating on a computer, phone, or tablet.
They also tend to perform more incomplete blinks.
A complete blink helps spread oils from the eyelid glands across the tear surface.
When blinking decreases, the tear film becomes less stable and evaporates more easily.
This is why patients with evaporative dry eye often notice worse symptoms after:
working at a computer
scrolling on a phone
reading for long periods
gaming
watching television
Medication helps address one part of the problem, while better blinking habits and screen breaks also support the tear film.
20. What environmental factors worsen tear evaporation?
Symptoms often become worse in environments that increase airflow or reduce humidity.
Common triggers include:
air conditioning
heating
fans
wind
airplanes
dry climates
prolonged driving with vents directed toward the face
Patients with MGD often notice that their eyes feel comfortable in one environment and significantly worse in another.
That pattern is another clue that evaporation is contributing to dry eye symptoms.
21. Why does dry eye sometimes cause blurry vision?
A healthy tear film forms the first smooth optical surface that light passes through when entering the eye.
When tears break up too quickly, that surface becomes irregular.
Vision then fluctuates.
A patient might notice:
blur that clears after blinking
difficulty focusing after screen use
words becoming less sharp while reading
vision changing throughout the day
This type of fluctuating vision differs from permanent retinal or optic nerve damage.
Persistent or sudden vision loss still deserves a full eye examination rather than being blamed automatically on dry eye.
22. Does dry eye cause permanent vision loss?
Typical dry eye disease usually causes discomfort and fluctuating vision rather than permanent severe visual loss.
Severe untreated ocular surface disease, however, sometimes damages the cornea.
More importantly, symptoms described as "blurry vision" have many possible causes.
Retinal disease, cataracts, glaucoma, corneal disease, and other conditions also affect vision.
If blur is persistent, worsening, or different in one eye, an eye examination helps identify the true cause.
23. What other treatments help evaporative dry eye?
Dry eye management often combines several approaches.
Depending on the cause, treatment includes:
preservative-free lubricating drops
warm compresses
lid hygiene
prescription medications
management of meibomian gland dysfunction
environmental changes
screen breaks
improved blinking
treatment of associated eyelid disease
There is no single treatment plan that fits every patient.
24. When should you ask about MIEBO?
It is worth discussing prescription dry eye treatment if:
artificial tears provide only short-lived relief
your eyes worsen with screens or airflow
you have been diagnosed with MGD
your vision fluctuates when your eyes feel dry
your eyes frequently burn or feel gritty
contact lens comfort has decreased
dry eye symptoms continue despite basic treatment
An examination of the tear film, eyelids, cornea, and meibomian glands helps determine whether an anti-evaporative treatment fits your situation.
25. When is blurry vision not simply dry eye?
Seek prompt evaluation if you experience:
sudden loss of vision
a new dark area
a curtain or shadow
new flashes
a sudden increase in floaters
severe eye pain
major redness with worsening vision
Those symptoms point toward problems beyond routine dry eye disease.
Do not rely on dry eye drops to treat an unexplained sudden change in vision.
What this means for your eyes
MIEBO adds a different approach to dry eye treatment.
Instead of primarily adding moisture or targeting inflammation, perfluorohexyloctane forms a thin layer over the tear film that is expected to reduce evaporation.
This makes it particularly relevant to evaporative dry eye and the tear-film problems often associated with meibomian gland dysfunction.
MIEBO is a prescription treatment, not a general-purpose artificial tear.
The right dry eye treatment depends on what is causing the tear film to break down in the first place.
An eye examination helps separate excessive evaporation from low tear production, inflammation, eyelid disease, and other causes of persistent symptoms.
Book with South Bay Retina
If persistent dryness, burning, gritty eyes, or fluctuating vision are interfering with your daily routine, schedule an eye evaluation with South Bay Retina.
Identifying what is contributing to your dry eye symptoms helps determine which treatment options are appropriate for your eyes.
Comments